Skip to main content

Advertisement

Log in

Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Cardiac amyloidosis has a poor prognosis, and high mortality and is often misdiagnosed as hypertrophic cardiomyopathy, leading to delayed diagnosis. Machine learning combined with speckle tracking echocardiography was proposed to automate differentiating two conditions. A total of 74 patients with pathologically confirmed monoclonal immunoglobulin light chain cardiac amyloidosis and 64 patients with hypertrophic cardiomyopathy were enrolled from June 2015 to November 2018. Machine learning models utilizing traditional and advanced algorithms were established and determined the most significant predictors. The performance was evaluated by the receiver operating characteristic curve (ROC) and the area under the curve (AUC). With clinical and echocardiography data, all models showed great discriminative performance (AUC > 0.9). Compared with logistic regression (AUC 0.91), machine learning such as support vector machine (AUC 0.95, p = 0.477), random forest (AUC 0.97, p = 0.301) and gradient boosting machine (AUC 0.98, p = 0.230) demonstrated similar capability to distinguish cardiac amyloidosis and hypertrophic cardiomyopathy. With speckle tracking echocardiography, the predictive performance of the voting model was similar to that of LightGBM (AUC was 0.86 for both), while the AUC of XGBoost was slightly lower (AUC 0.84). In fivefold cross-validation, the voting model was more robust globally and superior to the single model in some test sets. Data-driven machine learning had shown admirable performance in differentiating two conditions and could automatically integrate abundant variables to identify the most discriminating predictors without making preassumptions. In the era of big data, automated machine learning will help to identify patients with cardiac amyloidosis and timely and effectively intervene, thus improving the outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Falk RH, Alexander KM, Liao R et al (2016) AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 68(12):1323–1341. https://doi.org/10.1016/j.jacc.2016.06.053

    Article  Google Scholar 

  2. Ruberg FL, Grogan M, Hanna M et al (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(22):2872–2891. https://doi.org/10.1016/j.jacc.2019.04.003

    Article  CAS  Google Scholar 

  3. Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet (London, England) 387(10038):2641–2654. https://doi.org/10.1016/s0140-6736(15)01274-x

    Article  CAS  Google Scholar 

  4. Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442–1448. https://doi.org/10.1136/heartjnl-2012-302353

    Article  Google Scholar 

  5. Motwani M, Dey D, Berman DS et al (2017) Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J 38(7):500–507. https://doi.org/10.1093/eurheartj/ehw188

    Article  Google Scholar 

  6. Sanchez-Martinez S, Duchateau N, Erdei T et al (2018) Machine learning analysis of left ventricular function to characterize heart failure with preserved ejection fraction. Circ Cardiovasc Imaging 11(4):e007138. https://doi.org/10.1161/circimaging.117.007138

    Article  Google Scholar 

  7. Narula S, Shameer K, Salem Omar AM et al (2016) Machine-learning algorithms to automate morphological and functional assessments in 2D echocardiography. J Am Coll Cardiol 68(21):2287–2295. https://doi.org/10.1016/j.jacc.2016.08.062

    Article  Google Scholar 

  8. Sengupta PP, Huang YM, Bansal M et al (2016) Cognitive machine-learning algorithm for cardiac imaging: a pilot study for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ Cardiovasc Imaging. https://doi.org/10.1161/circimaging.115.004330

    Article  Google Scholar 

  9. Awan SE, Bennamoun M, Sohel F et al (2019) Machine learning-based prediction of heart failure readmission or death: implications of choosing the right model and the right metrics. ESC Heart Fail 6(2):428–435. https://doi.org/10.1002/ehf2.12419

    Article  Google Scholar 

  10. Attia ZI, Noseworthy PA, Lopez-Jimenez F et al (2019) An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet (London, England) 394(10201):861–867. https://doi.org/10.1016/s0140-6736(19)31721-0

    Article  Google Scholar 

  11. Raj S, Ray KC (2018) A personalized arrhythmia monitoring platform. Sci Rep 8(1):11395. https://doi.org/10.1038/s41598-018-29690-2

    Article  CAS  Google Scholar 

  12. Dorbala S, Ando Y, Bokhari S et al (2019) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. J Card Fail 25(11):e1–e39. https://doi.org/10.1016/j.cardfail.2019.08.001

    Article  Google Scholar 

  13. Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation 142(25):e533–e557. https://doi.org/10.1161/cir.0000000000000938

    Article  Google Scholar 

  14. Churpek MM, Yuen TC, Winslow C et al (2016) Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med 44(2):368–374. https://doi.org/10.1097/ccm.0000000000001571

    Article  Google Scholar 

  15. Mortazavi BJ, Bucholz EM, Desai NR et al (2019) Comparison of machine learning methods with national cardiovascular data registry models for prediction of risk of bleeding after percutaneous coronary intervention. JAMA Netw Open 2(7):e196835. https://doi.org/10.1001/jamanetworkopen.2019.6835

    Article  Google Scholar 

  16. Al’Aref SJ, Singh G, van Rosendael AR et al (2019) Determinants of in-hospital mortality after percutaneous coronary intervention: a machine learning approach. J Am Heart Assoc 8(5):e011160. https://doi.org/10.1161/jaha.118.011160

    Article  Google Scholar 

  17. Sun JP, Stewart WJ, Yang XS et al (2009) Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 103(3):411–415. https://doi.org/10.1016/j.amjcard.2008.09.102

    Article  Google Scholar 

  18. Di Bella G, Minutoli F, Pingitore A et al (2011) Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy. Circ J 75(5):1200–1208. https://doi.org/10.1253/circj.cj-10-0844

    Article  Google Scholar 

  19. Baccouche H, Maunz M, Beck T et al (2012) Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography 29(6):668–677. https://doi.org/10.1111/j.1540-8175.2012.01680.x

    Article  Google Scholar 

  20. Liu D, Hu K, Niemann M et al (2013) Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging 6(6):1066–1072. https://doi.org/10.1161/circimaging.113.000683

    Article  Google Scholar 

  21. Pagourelias ED, Mirea O, Duchenne J et al (2017) Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters. Circ Cardiovasc Imaging 10(3):e005588. https://doi.org/10.1161/circimaging.116.005588

    Article  Google Scholar 

  22. Boldrini M, Cappelli F, Chacko L et al (2020) Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13(4):909–920. https://doi.org/10.1016/j.jcmg.2019.10.011

    Article  Google Scholar 

  23. Zhang J, Gajjala S, Agrawal P et al (2018) Fully automated echocardiogram interpretation in clinical practice. Circulation 138(16):1623–1635. https://doi.org/10.1161/circulationaha.118.034338

    Article  Google Scholar 

  24. Shameer K, Johnson KW, Glicksberg BS et al (2018) Machine learning in cardiovascular medicine: are we there yet? Heart 104(14):1156–1164. https://doi.org/10.1136/heartjnl-2017-311198

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Xiao-Jun Chen for providing purely technical help.

Funding

This research did not receive any specific grant from funding: agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

ZW as the first author collected data, drafted, and revised the manuscript. JZ and LK contributed to the acquisition, analysis, and interpretation of data. HY is the corresponding author, who performed the conception and design of the study, and the final approval of the submitted manuscript.

Corresponding author

Correspondence to Hui Yan.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethical approval

All of the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (No. IIT20200654A).

Consent for publication

Consent for publication was obtained for every individual person’s data included in the study.

Informed consent

Informed consent was obtained from all of the individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, ZW., Zheng, JL., Kuang, L. et al. Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 39, 339–348 (2023). https://doi.org/10.1007/s10554-022-02738-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-022-02738-1

Keywords

Navigation